ФАСЕТОЧНЫЙ СИНДРОМ
Номер журнала:
10
Год издания:
2015
Среди причин болей в спине фасеточный синдром занимает одно из ведущих мест. Диагностировать болевой синдром позволяет комплексное клинико-диагностическое обследование, а купировать – целенаправленная и мультимодальная терапия, включающая нестероидные противовоспалительные препараты, блокады с местным анестетиком и кортикостероидом, а также радиочастотную денервацию и фасетопластику.
Ключевые слова:
боль в спине
фасеточный синдром
нестероидные противовоспалительные препараты
Для цитирования
Давыдов О., Павлова Л., Жуков Е. ФАСЕТОЧНЫЙ СИНДРОМ
. Врач, 2015; (10): 8-14 Список литературы:
- Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet. – 2015; pii: S0140-6736(15)60692-4
- Матросов Д.Н., Галушко Е.А., Эрдес Ш.Ф. Эпидемиология болей в ниж ней части спины в амбулаторной практике // Боль. – 2009; 4 (25): 23–8.
- Koes B., van Tulder M., Lin C. et al. An updated overview of clinical guidelines for the management of non-specific low back pain in primary care // Eur. Spine J. – 2010; 19 (12): 2075–94.
- Manchikanti L., Singh V., Pampati V. et al. Evaluation of the relative contributions of various structures in chronic low back pain // Pain Physician. – 2001; 4 (4): 308–16.
- Schwarzer A., Wang S., Bogduk N. et al. Prevalence and clinical features of lumbar zygapophysial joint pain: A study in an Australian population with chronic low back pain // Am. Rheum. Dis. – 1995; 54: 100–6.
- Manchikanti L., Pampati V., Fellows B. et al. Prevalence of lumbar facet joint pain in chronic low back pain // Pain Physician. – 1999; 2: 59–64.
- Cohen S., Raja S. Pathogenesis, diagnosis, and treatment of lumbar 7. zygapophyseal (facet) joint pain // Anesthesiology. – 2007; 106: 591–614.
- Bogduk N. Lumbar Facet Syndrome, In Pain Management. Еd. by S. Waldman, W. Saunders / Philadelphia, 2007; р. 769–76.
- Kalichman L. et al. Facet joint osteoarthritis and low back pain in the community-based population // Spine (Phila Pa 1976). – 2008; 33: 2560–5.
- Beresford Z., Kendall R., Willick S. Lumbar facet syndromes // Curr. Sports Med. Rep. – 2010; 9 (1): 50–6.
- Varlotta G., Lefkowitz T., Schweitzer M. et al. The lumbar facet joint: a review of current knowledge: part 1: anatomy, biomechanics, and grading // Skeletal. Radiol. – 2011; 40 (1): 13–23.
- Igarashi A., Kikuchi S., Konno S. et al. Inflammatory cytokines released from the facet joint tissue in degenerative lumbar spinal disorders // Spine (Phila Pa 1976). – 2004; 29 (19): 2091–5.
- Genevay S., Finckh A., Payer M. et al. Elevated levels of tumor necrosis factor-alpha in periradicular fat tissue in patients with radiculopathy from herniated disc // Spine (Phila Pa 1976). – 2008; 33 (19): 2041–6.vanKleef M. et al.
- Pain originating from the lumbar facet joints // Pain 14. Pract. – 2010; 10: 459–69.
- Gellhorn A., Katz J., Suri P. Osteoarthritis of the spine: the facet joints // Nat. 15. Rev. Rheumatol. – 2013; 9 (4): 216–24.
- Dwyer A., Aprill C., Bogduk N. Cervical zygapophyseal joint pain patterns. I: A study in normal volunteers // Spine (Phila Pa 1976). – 1990; 15 (6): 453–7
- Revel M., Poiraudeau S., Auleley G. et al. Capacity of the clinical picture to characterize low back pain relieved by facet joint anesthesia: Proposed criteria to identify patients with painful facet joints // Spine. – 1998; 23 (18): 1972–6.
- Подчуфарова Е.В. Боль в спине. В кн.: Боль (практическое руководство для врачей). Под ред. Н.Н. Яхно, М.Л. Кукушкина / М.: Издательство РАМН, 2011; с. 230–97.
- Воробьева О.В. Фасеточный синдром как причина боли в спине // Эффективная фармакотерапия. – 2012; 1: 4–9.
- Chou R., Huffman L. American Pain Society; American College of Physicians. Medications for acute and chronic low back pain: a review of the evidence for an American Pain ociety / American College of Physicians clinical practice guideline // Ann. Intern. Med. – 2007; 147 (7): 505–14.
- Каратеев А.Е., Насонов Е.Л., Яхно Н.Н. и др. Клинические рекоменда ции «Рациональное применение нестероидных противовоспалительных пре-паратов (НПВП) в клинической практике» // Современная ревматология. – 2015; 1: 4–24
- Хабиров Ф.А., Хабирова Ю.Ф. Боль в шее и спине. Рук. для врачей / Казань: Медицина, 2014; 503 с.
- Амелин А.В., Давыдов О.С. Фармакотерапия боли. В кн.: Боль (практи ческое руководство для врачей). Под ред. Н.Н. Яхно, М.Л. Кукушкина / М.: Издательство РАМН, 2011; с. 89–144.
- De Vecchis R., Baldi C., Di Biase G. et al. Cardiovascular risk associated with celecoxib or etoricoxib: ameta-analysis of randomized controlled trials which adopted comparison withplacebo or naproxen // Minerva Cardioangiol. – 2014; 62 (6): 437–48.
- Ramey D., Watson D., Yu C. et al. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis // Curr. Med. Res. Opin. – 2005; 21 (5): 715–22.
- Jensen M., Schnitzer T., Wang H. et al. Sensitivity of single-domain versus multiple-domain outcome measures to identify responders in chronic low-back pain: pooled analysis of 2 placebo-controlledtrials of etoricoxib // Clin. J. Pain. – 2012; 28 (1): 1–7.
- Zerbini C., Ozturk Z., Grifka J. et al. Efficacy of etoricoxib 60mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4-week, multinational, randomized,double-blind study // Curr. Med. Res. Opin. – 2005; 21 (12): 2037–49.
- Birbara C., Puopolo A., Munoz D. et al. Treatment of chronic low back pain withetoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial // J. Pain. – 2003; 4 (6): 307–15.
- Sheldon E., Bird S., Smugar S. et al. Correlation of measures ofpain function, and overall response: results pooled from two identical studiesof etoricoxib in chronic low back pain // Spine (Phila Pa 1976). – 2008; 33 (5): 533–8.
- Moore R., Moore O., Derry S. et al. Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice // Ann. Rheum. Dis. – 2010; 69: 374–9.
- Malmstrom K., Sapre A., Couglin H. et al. Etoricoxib in acute pain associated with dental surgery: a randomized,double-blind, placebo- and active comparator-controlled dose-ranging study // Clin. Ther. – 2004; 26 (5): 667–79.
- Auvinet B., Ziller R., Appelboom T. et al. Comparison of the onset 32. andintensity of action of intramuscular meloxicam and oral meloxicam in patientswith acute sciatica // Clin. Ther. – 1995; 17 (6): 1078–98.
- Chou R., Huffman L. American Pain Society; American College of Physicians. 33. Nonpharmacologic therapies for acute and chronic low back pain: a review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline // Ann. Intern. Med. – 2007; 147 (7): 492–504.
- Chou R., Hashimoto R., Friedly J. et al. Pain Management Injection 34. Therapies for Low Back Pain [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2015 Mar. AHRQ Technology Assessments.